122 related articles for article (PubMed ID: 7046321)
1. Discrimination of renovascular from essential hypertension by converting enzyme inhibition with an orally active compound.
Fagard R; Amery A; Lijnen P; Roussel-Deruyck R
Acta Clin Belg; 1982; 37(1):13-22. PubMed ID: 7046321
[No Abstract] [Full Text] [Related]
2. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225).
Imai Y; Abe K; Otsuka Y; Sakurai Y; Yoshinaga K
Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048
[TBL] [Abstract][Full Text] [Related]
3. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
Case DB; Atlas SA; Laragh JH
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
[TBL] [Abstract][Full Text] [Related]
4. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
Zawada ET; Stinson J; Ramirez G
Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
[TBL] [Abstract][Full Text] [Related]
5. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension.
Imai Y; Abe K; Otsuka Y; Sakurai Y; Ito T; Sato M; Haruyama T; Omata K; Hiwatari M; Yoshinaga K
Jpn Heart J; 1980 Nov; 21(6):793-802. PubMed ID: 7007685
[TBL] [Abstract][Full Text] [Related]
6. Use of captopril in the diagnosis of renal hypertension.
McGrath BP; Matthews PG; Johnston CI
Aust N Z J Med; 1981 Aug; 11(4):359-63. PubMed ID: 7030291
[TBL] [Abstract][Full Text] [Related]
7. Captopril in renovascular hypertension: long-term use in predicting surgical outcome.
Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI
Br Med J (Clin Res Ed); 1982 Mar; 284(6317):689-93. PubMed ID: 6802290
[TBL] [Abstract][Full Text] [Related]
8. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
Atkinson AB; Brown JJ; Davies DL; Leckie B; Lever AF; Morton JJ; Robertson JI
Hypertension; 1981; 3(1):53-8. PubMed ID: 7009427
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
[No Abstract] [Full Text] [Related]
10. [Effect of captopril on renal vein plasma renin ratio--diagnosis and predicting response to surgery in renovascular hypertension].
Takata M; Sugimoto T; Mikawa M; Yoshida K; Iuchi K; Iida H; Mizumura Y; Nakada T; Kawahara Y
Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1017-26. PubMed ID: 6366302
[No Abstract] [Full Text] [Related]
11. Maximal discrimination of renovascular from essential hypertension by the saralasin test.
Maxwell MH; Varady P; Zawada ET; Burkhalter JF; Waks U; Marks L
Clin Sci Mol Med Suppl; 1978 Dec; 4():297s-299s. PubMed ID: 282071
[No Abstract] [Full Text] [Related]
12. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
Ueda Y; Honda M; Hatano M
Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
[TBL] [Abstract][Full Text] [Related]
13. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
[No Abstract] [Full Text] [Related]
14. [Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension].
Irabu N; Nakamura K; Morohashi Y; Murakami S; Kawamura K
Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1029-39. PubMed ID: 6298493
[No Abstract] [Full Text] [Related]
15. [The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
Giuliani L; Martorana G; Giberti C
Minerva Nefrol; 1979; 26(4):623-8. PubMed ID: 396491
[No Abstract] [Full Text] [Related]
16. Diagnosis of unilateral renovascular hypertension: comparative effect of intravenous enalaprilat and oral captopril.
Tunny TJ; Klemm SA; Hamlet SM; Gordon RD
J Urol; 1988 Oct; 140(4):713-5. PubMed ID: 2843688
[TBL] [Abstract][Full Text] [Related]
17. Role of aldosterone in experimental hypertension.
McCaa RE; McCaa CS; Bengis RG; Guyton AC
J Endocrinol; 1979 May; 81(2):69P-78P. PubMed ID: 222873
[No Abstract] [Full Text] [Related]
18. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
19. A new syndrome: angiotensin-converting enzyme dysfunction syndrome: differential diagnosis and pathogenesis--case reports.
Umeki S; Terao A; Sawayama T
Angiology; 1988 Jan; 39(1 Pt 1):58-67. PubMed ID: 3277490
[TBL] [Abstract][Full Text] [Related]
20. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
Case DB; Laragh JH
Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
